Tiagabine Hydrochloride
- Product NDC
- 69238-1105
- 11-digit product format
- 692381105
- Labeler code
- 69238
- Product ID
- 69238-1105_012eca85-d949-4fd3-863e-1fac922150b3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tiagabine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA208181
- Marketing category
- ANDA
- Marketing start
- 2017-12-08
- Marketing end
- 0000-00-00
- Substance
- TIAGABINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-1105 | TIAGABINE HYDROCHLORIDE (TIAGABINE) TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 7 | Legacy NDC | 20240102_7036c6df-6527-4701-b484-6b962914b52a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69238-1105-3 | 69238110503 | 30 TABLET in 1 BOTTLE (69238-1105-3) | 30 tablet | 2017-12-08 | 0000-00-00 | No | No | Current |